114 related articles for article (PubMed ID: 1323620)
1. Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants.
Wetzler LM; Blake MS; Barry K; Gotschlich EC
J Infect Dis; 1992 Sep; 166(3):551-5. PubMed ID: 1323620
[TBL] [Abstract][Full Text] [Related]
2. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations.
Wetzler LM; Blake MS; Gotschlich EC
J Exp Med; 1988 Nov; 168(5):1883-97. PubMed ID: 3141555
[TBL] [Abstract][Full Text] [Related]
3. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.
Wetzler LM; Blake MS; Gotschlich EC
Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644
[No Abstract] [Full Text] [Related]
4. GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3.
Livingston PO; Calves MJ; Helling F; Zollinger WD; Blake MS; Lowell GH
Vaccine; 1993 Sep; 11(12):1199-204. PubMed ID: 8256501
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of purified recombinant outer membrane porin protein I of Neisseria gonorrhoeae.
Elkins C; Barkley KB; Carbonetti NH; Coimbre AJ; Sparling PF
Mol Microbiol; 1994 Dec; 14(5):1059-75. PubMed ID: 7715444
[TBL] [Abstract][Full Text] [Related]
6. Biophysical and antigenic characterization of gonococcal protein I incorporated into liposomes.
Parmar MM; Blake MS; Madden TD
Vaccine; 1997 Oct; 15(15):1641-51. PubMed ID: 9364695
[TBL] [Abstract][Full Text] [Related]
7. Developing a gonococcal protein I vaccine.
Blake MS; Wetzler LM; Gotschlich EC; Rice PA
Adv Exp Med Biol; 1989; 251():315-27. PubMed ID: 2514585
[No Abstract] [Full Text] [Related]
8. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.
Jiskoot W; Teerlink T; Van Hoof MM; Bartels K; Kanhai V; Crommelin DJ; Beuvery EC
Infect Immun; 1986 Nov; 54(2):333-8. PubMed ID: 3095239
[TBL] [Abstract][Full Text] [Related]
10. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens.
Francis IP; Lui X; Wetzler LM
Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622
[TBL] [Abstract][Full Text] [Related]
11. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
Rothbard JB; Schoolnik GK
Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
[No Abstract] [Full Text] [Related]
12. Antigenic and immunogenic properties of cyanogen bromide peptides from gonococcal outer membrane protein IB. Evidence for the existence of a surface-exposed conserved epitope.
Teerlink T; Versantvoort H; Beuvery EC
J Exp Med; 1987 Jul; 166(1):63-76. PubMed ID: 2439639
[TBL] [Abstract][Full Text] [Related]
13. The interaction of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae with normal human serum.
Pettit RK; Judd RC
Mol Microbiol; 1992 Mar; 6(6):729-34. PubMed ID: 1574002
[TBL] [Abstract][Full Text] [Related]
14. Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain.
Li G; Xie R; Zhu X; Mao Y; Liu S; Jiao H; Yan H; Xiong K; Ji M
PLoS One; 2014; 9(3):e90525. PubMed ID: 24594737
[TBL] [Abstract][Full Text] [Related]
15. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
16. Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines.
Wetzler LM
Ann N Y Acad Sci; 1994 Aug; 730():367-70. PubMed ID: 8080211
[No Abstract] [Full Text] [Related]
17. Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.
Kersten GF; van de Put AM; Teerlink T; Beuvery EC; Crommelin DJ
Infect Immun; 1988 Jun; 56(6):1661-4. PubMed ID: 3131250
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
19. Induction of mucosal immunoglobulin A immune response by preparations of Neisseria gonorrhoeae porin proteins.
Jeurissen SH; Sminia T; Beuvery EC
Infect Immun; 1987 Jan; 55(1):253-7. PubMed ID: 3025099
[TBL] [Abstract][Full Text] [Related]
20. Characterisation and immune responses to meningococcal recombinant porin complexes incorporated into liposomes.
Sánchez S; Abel A; Marzoa J; Gorringe A; Criado T; Ferreirós CM
Vaccine; 2009 Aug; 27(39):5338-43. PubMed ID: 19607954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
